Jacob Kenny

Dr Jacob Kenny is a Lecturer in the Department of Pathology and Laboratory Science within the School of Biomedical Sciences at the University of Western Australia. His dual focus spans teaching-intensive academic responsibilities and active research in bone pathology and regenerative medicine.

Education:

• Doctor of Philosophy in Pathology, University of Western Australia (awarded 11 December 2018) for research on "Identification of Genes Regulating Osteoarthritis Development Using A Mouse Phenotype Library".

Research Interests: Specializing in histopathology and regenerative biology, Dr Kenny investigates degenerative musculoskeletal diseases with emphasis on osteoarthritis and osteoporosis. His work integrates genome-wide association studies with translational research on bone tissue viability, operative assistance systems, and medical device development for orthopaedic applications. Current projects explore molecular mechanisms of bone resorption and formation.

Research Trends: Analysis of his 17 publications (2020-2024) reveals consistent focus on bone cell biology, particularly osteoclast/osteoblast interactions in disease states. Key themes include genetic regulation of bone disorders, reactive oxygen species signaling, and therapeutic interventions targeting RANKL pathways. His work bridges fundamental molecular research with clinical orthopaedics, showing increasing emphasis on angiogenic proteins and medical device innovation.

Grants and Projects: Dr Kenny actively leads three major research initiatives:

• Developing a Model of Human Microvasculature (Royal Perth Hospital Medical Research Foundation, 2025-2026)
• Redox imbalance as a driver and therapeutic target for acute lymphoblastic leukaemia (Department of Health WA, 2023-2026)
• Developing a novel angiogenic protein to heal broken bones (Department of Health WA, 2023-2024)

Collaborative Network: His research demonstrates extensive national and international collaboration, evidenced by co-authorship on high-impact publications across pharmacology, genetics, and bone biology domains, with significant citation impact (864 citations, h-index 12).